MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time.

Collaboration will utilize PacBio’s highly accurate HiFi sequencing to solve rare pediatric genetic diseases that have proven intractable in previous studies KANSAS CITY, Mo. , and MENLO PARK, Calif. , Oct. 15, 2020 (GLOBE NEWSWIRE) -- Children’s Mercy Kansas City, one of the nation’s top pediatric

New system features advanced on-instrument data processing and cloud enablement to deliver HiFi data faster and with significant reduction in compute and data storage costs MENLO PARK, Calif. , Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California , Inc. (Nasdaq:PACB), a leading

MENLO PARK, Calif. , Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of

MENLO PARK, Calif. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares of its common stock at a price to the

MENLO PARK, Calif. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering.  Pacific Biosciences also intends to grant the underwriters

Christian O. Henry Named Chief Executive Officer John F. Milligan , Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO MENLO PARK, Calif. , Aug. 07, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes,

MENLO PARK, Calif. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020 . Total revenue for the second quarter of 2020 was $17.1 million , compared with $24.6 million for the same

Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome AUSTIN, Texas and MENLO PARK, Calif. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California , Inc. (Nasdaq:PACB), a leading provider of

MENLO PARK, Calif. , July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results on Monday, August 3, 2020 , at 4:30pm Eastern Time .